) mouse is a well-established model of cholestatic cholangiopathies. Female Mdr2 -/-mice develop more severe hepatobiliary damage than male Mdr2 -/-mice, which is correlated with a higher proportion of taurocholate in the bile. Although estrogen has been identified as an important player in intrahepatic cholestasis, the underlying molecular mechanisms of gender-based disparity of cholestatic injury remain unclear. The long noncoding RNA H19 is an imprinted, maternally expressed, and estrogen-targeted gene, which is significantly induced in human fibrotic/cirrhotic liver and bile duct-ligated mouse liver. However, whether aberrant expression of H19 accounts for gender-based disparity of cholestatic injury in Mdr2
]), has provided a very useful tool to study the disease pathology of chronic biliary liver disease and test potential therapeutics. (1, 2) Interestingly, previous studies found that female Mdr2 -/-mice developed more severe cholestatic liver injury with a more Abbreviations: ALP, alkaline phosphatase; ALT, alanine transaminase; AMPK, adenosine monophosphate-activated protein kinase; AST, aspartate transaminase; BDL, bile duct ligation; CK-19, cytokeratin 19; E2, 17b-estradiol; ER, estrogen receptor; ERK1/2, extracellular signal-regulated kinase 1/2; FXR, farnesoid X receptor; lncRNA, long noncoding RNA; Mdr2 -/-, multidrug resistance 2 gene knockout; MLE, mouse large cholangiocyte; PCNA, proliferating cell nuclear antigen; PSC, primary sclerosing cholangitis; S1PR2, sphingosine 1-phosphate receptor 2; SHP, small heterodimer partner; shRNA, short hairpin RNA; a-SMA, alpha-smooth muscle actin; TBA, total bile acid; TCA, taurocholate; WT, wild type.
hydrophobic bile acid pool composition and higher levels of taurocholate (TCA) in the bile when compared to their male counterparts. (3) Although it is well known that female hormones play a critical role in the induction of cholestatic injury, the underlying cellular/ molecular mechanisms accounting for the gender disparity of cholestatic liver injury remain to be determined. (4) (5) (6) Our previous studies reported that conjugated bile acids, especially TCA, promote invasive growth of cholangiocarcinoma through activation of sphingosine 1-phosphate receptor 2 (S1PR2) and up-regulation of cyclooxygenase 2. (7, 8) Recently, we determined that the S1PR2-mediated signaling pathway is also involved in bile duct ligation (BDL)-induced cholestasis and fibrosis. (9) TCA was also shown to be involved in estrogen-induced cholestasis. (10) These observations suggest that both TCA-mediated and estrogenmediated signaling pathways may contribute to the gender disparity of cholestatic liver injury.
The long noncoding RNA (lncRNA) H19 is an imprinted and maternally expressed gene. It is one of a few lncRNAs conserved between human and mouse and plays a key role in the regulation of cell proliferation and differentiation. (11) H19 is also an estrogenregulated transcript, and aberrant expression of H19 has been associated with cell proliferation and migration in a variety of cancers, including gastric, gallbladder, and pancreatic cancers. (12, 13) It is also upregulated in animal models of CCl 4 -induced cirrhosis and BDL-induced fibrosis. (14, 15) However, there is a gap in our knowledge about the mechanism by which bile acids and estrogen-mediated signaling regulate H19 expression, and the role of H19 in the gender disparity of cholestatic liver injury in Mdr2 -/-mice remains unknown.
In the present study, we report that H19 is predominantly expressed in cholangiocytes and that aberrant expression of H19 was correlated with the progression of fibrotic liver injury in female Mdr2 -/-mice. These findings suggest that the TCA/S1PR2-induced and estrogen-induced signaling pathways along with H19 play key roles in cholestatic liver injury.
Materials and Methods

MATERIALS
Detailed information on all chemicals and reagents used in this study is provided online in the Supporting Information.
Harbor, ME). Mdr2 -/-mice were gifts from Dr. Gianfranco Alpini (Texas A&M HSC College of Medicine). Mice were housed under a 12-hour light/dark cycle and fed standard chow and tap water ad libitum. Mice at different ages (60, 100, and 180 days) were used in this study. At the end of the experiment, mice were weighed and sacrificed. Blood and bile were collected to measure liver functional enzyme activities and bile acid and hydroxyproline concentrations. Livers were harvested and either fixed and processed for histological analysis or frozen in liquid nitrogen and stored at -808C for further analysis. For the in vivo knockdown of H19 experiment, female Mdr2 -/-mice (60 days) were injected with purified adenovirus (2 3 10 10 virus particles/mouse) through the tail vein. After 7 days, mice were harvested as described above. All animal study protocols were approved by the Institutional Animal Care and Use Committee of Virginia Commonwealth University. In addition, all experiments were performed in accordance with institutional guidelines and regulations.
HUMAN LIVER SAMPLES
Frozen primary sclerosing cholangitis (PSC) patient liver tissues and normal human liver tissues for age were obtained through the Liver Tissue Cell Distribution System (Minneapolis, MN), which was funded by National Institutes of Health contract HSN276201200017C.
MEASUREMENT OF THE LIVER FUNCTIONAL ENZYME ACTIVITIES, HYDROXYPROLINE, AND TOTAL BILE ACID LEVELS
Serum levels of alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and hydroxyproline were measured using commercially available assay kits from Sigma (St. Louis, MO) according to the manufacturer's instruction. Total bile acid (TBA) was measured by an assay kit from Crystal Chem (Downers Drive, IL). Liver samples were homogenized in radio immunoprecipitation assay buffer, and total protein lysates were used for analysis. Results were normalized with total protein amount. Absorption was determined by the Victor3 Multilabel Plate Counter from PerkinElmer (Waltham, MA).
All other methods are described in the Supporting Information.
Results
GENDER DISPARITY OF CHOLESTATIC LIVER INJURY IN
Mdr2
-/-MICE
We first compared the cholestatic liver injury in agematched male and female WT and Mdr2 -/-mice. Serum ALP and bile acid levels were dramatically increased in 100-day-old Mdr2 -/-mice compared to those in age-matched WT mice, especially in female Mdr2 -/-mice (Fig. 1A) . Similarly, hepatic ALP and bile acid levels were also increased significantly Mdr2 -/-mice (Supporting Fig. S1A ). Although serum levels of ALT and AST were increased in Mdr2 -/-mice compared to WT mice, there was no significant difference between male and female Mdr2 -/-mice (Supporting Fig. S1B ). In addition, the ratios of liver or spleen weight over body weight of female Mdr2 -/-mice were increased compared to their male counterparts (Supporting Fig. S1C ). Histological analysis revealed that female Mdr2 -/-mice had more severe cholestatic liver injury as illustrated by hematoxylin and eosin and Masson's trichrome staining (Fig. 1B) . Real-time PCR analysis showed that the mRNA steady-state level of collagen 1 was significantly increased in female, but not in male, Mdr2 -/-mice (Fig. 1C) . Consistently, the hepatic hydroxyproline level was increased in female, but not in male, Mdr2 -/-mice (Fig. 1D ). In addition, both real-time RT-PCR and western blot analysis showed increased levels of proliferating cell nuclear antigen (PCNA) in the livers of female Mdr2 -/-mice (Supporting Fig. S1D ; Fig.  1E ). Immunohistochemical staining further showed a significant increase of PCNA and cytokeratin 19 (CK-19) expression in female Mdr2 -/-mice, indicating ductal proliferation and increase of bile duct mass ( Fig.  1F; Supporting Fig. S1E ). Furthermore, expression of several inflammatory mediators (interleukin-6, tumor necrosis factor-a, chemokine [C-X-C motif] ligand 10, and chemokine [C-C motif] ligands 17 and 22) were also largely increased in female Mdr2 -/-mice, while male Mdr2 -/-mice had a slight or no increase when compared to gender-matched WT mice (Supporting Fig. S1F ).
To further determine if the gender disparity of biliary fibrosis is dependent on age, we compared younger Mdr2 -/-mice (60 days old) with older ones (100 days old). Sixty-day-old male Mdr2 -/-mice only developed mild biliary cholestatic injury, but 100-day-old female -/-mice (n 5 6). Abbreviation: H&E, hematoxylin and eosin.
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Mdr2 -/-mice developed significant cholestatic injury as indicated by an increase in serum ALP and TBA levels ( Fig. 2A ) and fibrosis as indicated by hematoxylin and eosin staining and Masson's trichrome staining (Fig. 2B ). Real-time PCR analysis indicated that there was no significant difference of Ki67 mRNA levels between male and female Mdr2 -/-mice at 60 days age, but Ki67 mRNA expression was much higher in female than male Mdr2 -/-mice at 100 days of age (Fig. 2C ). Although no significant change was observed in the PCNA mRNA levels between 60-dayold male and female Mdr2 -/-mice, the protein levels of PCNA were significantly up-regulated (Fig. 2D,E) . For 100-day-old Mdr2 -/-mice, PCNA mRNA and protein levels were both significantly increased in female and male mice. No significant changes in the AST and ALT levels were detected (Supporting Fig.  S2A ). The ratios of liver or spleen weight over the body weight and the mRNA levels of inflammatory mediators were similar between 60-day-old male and female Mdr2 -/-mice, but tumor necrosis factor-a, chemokine (C-X-C motif) ligand 10, and chemokine (C-C motif) ligand 17 were significantly up-regulated in 100-day-old female Mdr2 -/-mice (Supporting Fig.  S2B-D) . Immunohistochemical staining also showed a significant increase in PCNA and CK-19 expression in 60-day-old female Mdr2 -/-mice, which was more pronounced in 100-day-old female Mdr2 -/-mice ( 
ABERRANT EXPRESSION OF H19 IS CORRELATED WITH THE SEVERITY OF BILIARY FIBROSIS IN FEMALE Mdr2
The lncRNA H19 is an estrogen-regulated gene whose expression is suppressed in adult liver. (14) (15) (16) Aberrant expression of H19 has been associated with various cancers. (11, 13, (17) (18) (19) (20) H19 is also up-regulated in BDL mice. (16) To identify the role of H19 in the development of biliary fibrosis in Mdr2
-/-mice, we first examined the expression of hepatic H19 in WT and Mdr2 -/-mice. Expression of hepatic H19 in 100-day-old WT mice was very low with a slight but significant increase in male Mdr2 -/-mice (Fig. 3A ). In contrast, there was a striking 200-fold increase in hepatic H19 expression in female Mdr2 -/-mice. To further determine whether hepatic H19 expression was correlated to the fibrotic progression seen in female Mdr2 -/-mice, we compared hepatic H19 expression levels in 60-day-old Mdr2 -/-mice with that in 100-day-old Mdr2 -/-mice. At 60 days old, hepatic H19 levels were 6-fold higher in female than in male Mdr2 -/-mice; but at 100 days old, hepatic H19 levels were more than 20-fold higher in female Mdr2 -/-mice (Fig. 3B ). It has been reported that c-Myc induced H19 expression by allele-specific binding. (21) Expression levels of c-Myc were significantly increased in 100-day-old female Mdr2 -/-mice compared to agematched WT mice (Fig. 3C) . However, there was no significant difference between 60-day-old and 100-day-old female Mdr2 -/-mice (Fig. 3D) . Recently, it was reported that hepatic overexpression of Bcl-2 induced expression of H19 and rapid small heterodimer partner (SHP) protein degradation through activation of the caspase-8 pathway in WT mice. (16) However, expression of Bcl-2 in female Mdr2 -/-mice only increased slightly, and no change was observed in male Mdr2
-/-mice (Supporting Fig. S3A-D) . In addition, protein expression levels of farnesoid X receptor alpha (FXRa) and SHP were significantly downregulated in 100-day-old Mdr2 -/-mice when compared to those in 60-day-old Mdr2 -/-mice ( Fig. 3E ) but not the mRNA levels (Supporting Fig. S3E,F) . Moreover, the expression level of H19 was dramatically increased in older female Mdr2 -/-mice, which was accompanied by a significant down-regulation of SHP at 180 days (Supporting Fig. S4A,B) . Expression levels of ki67, PCNA, and collagen 1 were markedly upregulated in both 100-day-old and 180-day-old female mice (Supporting Fig. S4C-E) . The mRNA levels of Bcl-2 were mildly increased in female Mdr2 -/-mice at both 100 and 180 days of age (Supporting Fig. S4F ). These results suggest that Bcl-2 plays a minimal role in the up-regulation of H19 and down-regulation of SHP in aged female Mdr2 -/-mice.
BILE ACID RECEPTORS AND CHOLESTATIC INJURY IN
Mdr2 -/-MICE
A recent study reported that the G protein-coupled receptor TGR5 is required for bile acid-induced cholangiocyte proliferation in BDL models. (22) However, in both BDL mice and Mdr2 -/-mice, the most abundant bile acids accumulated in the liver are conjugated primary bile acids, which are weak agonists of TGR5. (3) Our previous studies reported that TCA activates S1PR2 in both hepatocytes and cholangiocytes. (7, 20, 23) TGR5 is expressed in nonparenchymal cells of liver, such as Kupffer cells and cholangiocytes, but not expressed in hepatocytes. (22) Recently, we reported that the expression level of S1PR2 in cholangiocytes was much higher than that of TGR5, and S1PR2 null mice were protected from BDL-induced hepatic biliary injury. (9) To determine whether S1PR2 plays a role in the up-regulation of H19 and cholestatic liver injury in female Mdr2
-/-mice, we first determined the mRNA levels of S1PR2. Hepatic S1PR2 was significantly up-regulated in both male and female Mdr2 -/-mice when compared to WT mice, especially in female Mdr2 -/-mice (Fig. 4A) .
Also, compared to 60-day-old female mice, 100-dayold female mice showed much higher levels of S1PR2 mRNA (Fig. 4B) . However, hepatic mRNA levels of TGR5 were not significantly different between WT and Mdr2 -/-mice (Supporting Fig.  S5A,B) . There was also no gender difference in -/-mice (C) and between 60-day-old and 100-day-old Mdr2 -/-mice (D). (E) Protein expression levels of FXR and SHP determined by western blot analysis and normalized with b-actin as an internal control. Statistical significance: *P < 0.05 compared with male WT mice; ## P < 0.01, ### P < 0.001 compared with female WT mice; $$ P < 0.01, $$$ P < 0.001 compared with 100-day-old male Mdr2 -/-mice (n 5 6).
TGR5 expression in Mdr2 -/-mice. We recently reported that S1PR2 is the predominant S1PR in cholangiocytes. (9) To further compare the expression levels in different types of hepatic cells, we isolated primary hepatocytes, cholangiocytes, and Kupffer cells from WT and Mdr2 -/-mice. S1PR2 was highly expressed in cholangiocytes from both male and female Mdr2 -/-mice and significantly up-regulated -/-mice. Statistical significance: *P < 0.05, ***P < 0.001 compared with male WT mice; # P < 0.05, ## P < 0.01, ### P < 0.001 compared with female WT mice; $$$ P < 0.001 compared with 100-day-old male Mdr2 -/-mice (n 5 6).
in hepatocytes and Kupffer cells from female Mdr2
-/-mice (Fig. 4C) . It is well known that estrogen induces cholestatic liver injury by activating estrogen receptor a (ERa), the major isoform expressed in the liver. (24) To determine whether the estrogen level was correlated to cholestatic liver injury in female Mdr2
-/-mice, we measured serum estradiol levels using an enzyme-linked immunosorbent assay kit. Estradiol levels were significantly increased in aged female Mdr2 -/-mice (100 and 180 days old) (Supporting Fig. S5C ). ERa expression was higher in female mice (both WT and Mdr2 -/-mice) than in male mice (Supporting Fig. S5D ). Although ERa is also expressed in cholangiocytes and Kupffer cells, the expression level was lower than that in hepatocytes (Supporting Fig. S5E ). Also, there was no significant difference of ERa expression in hepatocytes and cholangiocytes between WT and Mdr2 -/-mice, but Kupffer cells from female Mdr2 -/-mice had higher ERa levels compared to WT mice. Furthermore, H19 expression was strikingly up-regulated in the hepatocytes and cholangiocytes from female Mdr2 -/-mice, especially in cholangiocytes (Fig. 4D) .
EFFECT OF TCA AND ESTROGEN ON H19 EXPRESSION
Our previous studies showed that bile acids and estrogen activated extracellular signal-regulated kinase 1/2 (ERK1/2) and adenosine monophosphate-activated protein kinase (AMPK) signaling pathways in hepatocytes and cholangiocarcinoma cells. (6) (7) (8) 22) We further determined whether the ERK1/2 signaling pathway was involved in TCA-mediated and 17b-estradiol (E2)-mediated up-regulation of H19 using cultured mouse large cholangiocytes (MLEs). TCA rapidly induced ERK1/2 activation, while E2 had a delayed response (Fig. 5A,B) . Both TCA and E2 activated AMPK. In addition, both TCA and E2 upregulated H19 expression without an additive or synergistic effect (Fig. 5C ). By using a chemical inhibitor of mitogen-activated protein kinase (U0126) and chemical antagonists of S1PR2 and ERa (JTE-013 and ICI182,780, respectively), we found that both TCAinduced H19 expression and E2-induced H19 expression were blocked by U0126 as well as their corresponding antagonists (Fig. 5C ). In addition, both TCA and E2 significantly up-regulated alpha-smooth muscle actin (a-SMA), but both had no effect on Bcl-2 or collagen 1 mRNA levels. Cotreatment with TCA and E2 significantly increased mRNA levels of Bcl-2, a-SMA, and collagen 1, which was inhibited by U0126, a combination of JTE-013 and ICI182,780 ( Fig. 5C-E) , as well as by a specific short hairpin RNA (shRNA) of H19 (Fig. 6A-D) . Down-regulation of H19 had no effect on FXR mRNA levels (data not shown) but slightly up-regulated SHP mRNA expression in MLE cells (Fig. 6E) . However, H19 shRNA significantly blocked TCA-induced expression of S1PR2 in cholangiocytes (Fig. 6F) .
H19 KNOCKDOWN ALLEVIATED CHOLESTATIC LIVER INJURY IN FEMALE Mdr2
-/-MICE To further define the crucial role of H19 in cholestatic and fibrotic liver injury in female Mdr2 -/-mice, the adenovirus of H19 shRNA or control shRNA was injected through the tail vein to knock down the expression of H19 in female Mdr2 -/-mice. Downregulation of H19 in female Mdr2 -/-mice significantly reduced serum ALP and TBA levels but had no effect on ALT and AST ( Fig. 7A; Supporting Fig. S6 ). Histological analysis further showed that down-regulation of H19 markedly reduced hepatobiliary injury and fibrosis (Fig. 7B) . A previous study reported that overexpression of Bcl-2 induced rapid protein degradation of SHP. (15) However, there was no significant difference of Bcl-2 protein levels between 60-day-old and 100-day-old female Mdr2 -/-mice (Supporting Fig.  S3D ), while the SHP protein level in 100-day-old female Mdr2 -/-mice was strikingly low compared to that in 60-day-old female Mdr2 -/-mice (Fig. 3E ). H19 shRNA effectively down-regulated hepatic H19 levels and increased SHP mRNA (1.5 fold) and dramatically up-regulated SHP protein levels, which was accompanied by down-regulation of cytochrome P450 7A1 expression (Fig. 7C,D; Supporting Fig. S7A ). In addition, H19 knockdown in female Mdr2 -/-mice decreased Bcl-2, c-Myc, S1PR2, ERa, and PCNA expression but had no effect on FXR expression (Fig.  7C,D; Supporting Fig. S7C ). Immunohistochemical analysis of PCNA and CK-19 further showed that cholangiocyte proliferation was inhibited by H19 shRNA ( Fig. 7E; Supporting Fig. S7D ). Furthermore, H19 knockdown significantly reduced the mRNA levels of Ntcp and ABCG8 but induced the expression of Osta, suggesting a reduction of bile acid and cholesterol accumulation in hepatocytes (Supporting Fig.  S7E,F) .
ABERRANT EXPRESSION OF H19 IN FEMALE PSC PATIENTS
To further determine whether our findings in female , and ICI182,780 (1 lM) for 1 hour and then treated with vehicle control, TCA (100 lM) or E2 (100 nM), for 48 hours. Relative expression levels of H19 (C), mRNA levels of Bcl-2 (D), a-SMA (E), and collagen 1 (F) were determined by real-time RT-PCR and normalized using HPRT1. Statistical significance: *P < 0.05, **P < 0.01, ***P < 0.001 compared with vehicle control group; # P < 0.05 compared with E2 group; $ P < 0.05 compared with TCA group; U P < 0.05; UU P < 0.01 compared with the TCA1E2 group (n 5 3). Abbreviations: p-, phosphorylated; t-, total.
FIG. 6.
The role of H19 in TCA-mediated/E2-mediated expression of profibrotic genes in cholangiocytes. MLE cells were transduced with control or H19 shRNA adenovirus for 6 hours before treatment with a vehicle control, TCA (100 lM), E2 (100 nM), or TCA1E2 for 48 hours. Relative expression levels of H19 (A) and mRNA levels of a-SMA (B), Bcl-2 (C), collagen 1 (D), SHP (E), and S1PR2 (F) were determined by real-time RT-PCR and normalized using HPRT1 as an internal control. Statistical significance: *P < 0.05, **P < 0.01 compared with vehicle control group; # P < 0.05 compared with the control shRNA E2 group; $ P < 0.05, $$ P < 0.01 compared with the control shRNA TCA group; U P < 0.05, UU P < 0.01 compared with the control shRNA TCA1E2 group (n 5 3). Abbreviations: C, control; MOI, multiplicity of infection.
SHP, and S1PR2 observed in Mdr2
-/-mice (Supporting Fig. S8 ). Interestingly, S1PR2 was significantly up-regulated in all PSC patients, especially in female PSC patients.
Discussion
Mdr2
-/-mice have been widely used as a cholestatic biliary disease animal model, which recapitulates Mdr3 mutation-related hepatobiliary diseases in humans. (25) Interestingly, female Mdr2 -/-mice showed more severe cholestatic and fibrotic symptoms than their male counterparts, as evidenced by increased hepatic bile acids and fibrosis. (26, 27) Previous studies reported that the gender difference in injury in Mdr2 -/-mice was mainly due to the different requirement for bile acid and phospholipid secretion between female and male mice. (28) Furthermore, female Mdr2 -/-mice showed a higher proportion of TCA in bile salt pool composition than male Mdr2 -/-mice, which was also regarded as a potential cause of the gender difference in fibrotic injury. (3, 27) These studies suggest that both conjugated bile acids, mainly TCA, and estrogen play a critical role in gender disparity of cholestatic injury in Mdr2 -/-mice. However, the cellular/molecular mechanisms were unclear. In the present study, we identified that lncRNA H19 is instrumental in TCA-induced and estrogen-induced cholestatic injury in female Mdr2 -/-mice. It is well recognized that bile acids are important signaling molecules and play important roles in regulating lipid, glucose, and energy metabolism. (20, 29, 30) In the BDL-induced cholestatic model, levels of conjugated bile acids were significantly increased in both liver and serum. (31) We previously demonstrated that TCA-mediated activation of S1PR2 is responsible for the activation of ERK1/2 and AKT signaling pathways in primary hepatocytes (23) and invasive growth of cholangiocarcinoma cells. (7, 8) Our most recent studies reported that S1PR2 plays a critical role in BDLinduced cholestatic injury. (9) In the current study, we also found that hepatic S1PR2 expression was significantly up-regulated in Mdr2 -/-mice during progression of hepatic fibrosis (Fig. 4) . We further showed that the expression level of S1PR2 in primary hepatocytes isolated from female mice was significantly higher than that from male mice in both WT and Mdr2 -/-mice, but there was no significant gender difference in cholangiocytes. There is increasing evidence indicating that dysregulation of bile acid-mediated signaling pathways contributes to cholestatic liver diseases. Recently, it was reported that TGR5 is an important mediator of bile acid-induced cholangiocyte proliferation in vivo and in vitro. (22) It also has been reported that a dual FXR/TGR5 agonist, INT-767, significantly reduced hepatic inflammation and biliary fibrosis in Mdr2 -/-male mice, whereas a single agonist of FXR and TGR5 (INT-747 and INT-777, respectively) had no hepatoprotective effects. (32) However, the current study indicates that TGR5 expression levels are similar in both male and female Mdr2 -/-mice (Supporting Fig. S5 ). It has been reported that TGR5 is mainly activated by secondary bile acids and conjugated primary bile acids are weak agonists of TGR5. (33) Although TGR5 is expressed in cholangiocytes, its expression level is much lower compared to that of S1PR2. In addition, the most abundant bile acids accumulated in the liver of Mdr2 -/-mice are conjugated primary bile acids, and female Mdr2 -/-mice have a higher proportion of TCA in the bile.
(3) Therefore, S1PR2 may play a more crucial role than TGR5 in the gender disparity of cholestatic injury in Mdr2 -/-mice. Long noncoding RNAs have important biological functions, and H19 is one of the few wellcharacterized lncRNAs. Aberrant expression of H19 has been linked to various disease states. (20, 34) However, little is known about the role of H19 in cholestatic liver injury, especially in estrogen-mediated cholestasis. The current study indicates that H19 is a key player in promoting cholestatic injury in female Mdr2
-/-mice. The expression level of H19 was dramatically upregulated in cholangiocytes from female Mdr2 -/-mice (Fig. 4) . Estrogen has been well studied as a procholestatic agent in both in vitro cell culture and in vivo animal models. (35) We recently reported that estrogeninduced activation of cyclic adenosine monophosphate-ERK1/2-liver kinase B1-AMPK signaling pathways contributed to suppression of FXRa expression in hepatocytes, resulting in disruption of bile acid homeostasis. (6) While ER expression is relatively low in cholangiocytes under normal physiological conditions, its expression was, however, markedly increased in proliferating cholangiocytes. (5, 36) In the current study, we found that the mRNA levels of hepatic ERa are similar between WT and Mdr2 -/-female mice (Supporting Fig. S5C ). In contrast, the S1PR2 mRNA levels are markedly increased in Mdr2 -/-female mice (Fig. 4) . Interestingly, in cultured mouse cholangiocytes, both E2-induced up-regulation of H19 and TCA-induced up-regulation of H19 are inhibited by the mitogen-activated protein kinase inhibitor U0126 (Fig. 5C ). Our unpublished studies indicated that knockdown of S1PR2 in Mdr2 -/-mice significantly reduced hepatic H19 expression and fibrotic injury (data not shown). These findings suggest that TCA/S1PR2-mediated and estrogen/ERmediated activation of the ERK1/2 signaling pathway and subsequent up-regulation of H19 represent key events promoting cholestatic injury in female Mdr2 -/-mice. Furthermore, our findings in human PSC patients (Supporting Fig. S8 ) indicate that the Mdr2 -/-mouse is a suitable model for PSC. The gender disparity of cholestatic injury in Mdr2 -/-mice can be translated to PSC in human patients.
A recent study reported that adenovirus-mediated gene hepatic overexpression of Bcl-2 caused severe liver injury, fibrosis, and inflammation, which were accompanied by a significant induction of H19 and rapid SHP protein degradation through activation of the caspase-8 signaling pathway. (16) In our current study, we did not find significant differences of Bcl-2 expression levels between female WT and Mdr2 -/-mice. It was demonstrated that Bcl-2 expression has no correlation to H19 expression and the severity of hepatic fibrotic injury (Supporting Fig. S3 ). However, S1PR2 expression was significantly up-regulated during progression of fibrosis and correlated to aberrant expression of H19 (Fig. 4) . In addition, our results indicate that SHP protein levels are inversely related to H19 expression levels. Down-regulation of H19 in vivo strikingly up-regulated SHP expression at both the mRNA and protein levels (Fig. 7C,D) . Because SHP is mainly expressed in hepatocytes, while H19 is mainly expressed in cholangiocytes, how SHP expression is regulated by H19 remains to be determined. Our preliminary studies may suggest that cell-cell communication through extracellular vesicles may contribute to crosstalk between hepatocytes and cholangiocytes.
H19 has been identified not only as an estrogenregulated gene but also as a c-Myc-targeted gene. -/-mice. TCA-mediated activation of S1PR2 and estrogenmediated activation of ER further induce activation of ERK1/2 both in cholangiocytes and in hepatocytes. In cholangiocytes, both TCA and E2 up-regulate H19 expression, which further increases the expression of profibrotic genes such as cMyc, collagen 1, and Bcl-2. In hepatocytes, activation of ERK1/2 further induces phosphorylation of AMPK, which has been shown to inhibit FXR and SHP expression. In addition, the extracellular vesicles derived from cholangiocytes further down-regulate SHP expression, disrupt bile acid homeostasis, and ultimately cause hepatic cholestatic injury. H19 represents a potential candidate marker and a therapeutic target for cholestatic liver injury. Abbreviations: Bsep, bile salt export pump; ER, endoplasmic reticulum; EV, extracellular vesicle; LKB1, liver kinase B1; Mrp, multidrug resistance-associated protein; SphK2, sphingosine kinase 2.
Binding of c-Myc to evolutionarily conserved E-boxes near the imprinting control region of the H19 promoter facilitates histone acetylation and transcriptional initiation. Our current study indicates that c-Myc is significantly up-regulated in female Mdr2 -/-mice (Fig.  3C,D) . However, its expression level is not correlated to the severity of cholestatic injury. Although there is more severe hepatic injury in 100-day-old female Mdr2 -/-mice compared to 60-day-old female Mdr2
-/-mice, the c-Myc protein levels are similar (Fig. 3D) . In contrast, the H19 expression level is closely correlated to hepatic fibrotic injury. Down-regulation of H19 also mildly reduces hepatic c-Myc expression (Fig.  7D) . These results suggest that c-Myc-independent regulation of H19 expression plays a critical role in cholestatic injury in female Mdr2 -/-mice. Furthermore, consistent with our previous finding, (20) upregulation of hepatic S1PR2 was also correlated to the increased protein level of sphingosine kinase 2 in female Mdr2 -/-mice, which was blocked by H19 shRNA (Supporting Fig. S9 ).
In summary, based on our findings from previous and current studies, we propose that both TCAmediated activation of S1PR2 and estrogen-induced activation of ER induce subsequent activation of ERK1/2, which is responsible for up-regulation of H19 and sphingosine kinase 2 in cholangiocytes (Fig.  8) . The crosstalk between hepatocytes and cholangiocytes through extracellular vesicles results in suppression of SHP expression, disruption of bile acid homeostasis, and eventually hepatic cholestatic injury. H19 is a central player in the gender-related disparity of cholestatic injury in Mdr2 -/-mice and represents a potential therapeutic target for cholestatic diseases.
